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Abstract. This review article focuses on protein kinases
regulating the onset and transition through mitosis. The
essay begins by introducing the structural features of the
protein kinase catalytic domain and emphasizing the
mechanism of enzymatic activation of this class of pro-
teins. Next follows a short historical perspective on cell
division and a description of our current understanding of
mitosis. In the central part of the review I examine the
four major kinases that set the stage for mitosis, which
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consist of Cdk1, Polo-like 1, Nek2 and Aurora kinases.
For each entry dealt with, I focus particularly on studies
that have linked DNA damage response pathways to inhi-
bition of kinase activity, and I evaluate the conclusions
drawn. Finally, I examine protein kinases initially de-
scribed in the context of different cell cycle transitions
and only later proposed to be involved in the control of
mitosis.
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Protein phosphorylation
The year 2003 marked the 50th anniversary of the eluci-
dation of the double helical structure of DNA. The fol-
lowing year marked another important 50th anniversary:
the discovery of protein phosphorylation [1]. It is para-
digmatic that when phosphorylation was initially de-
scribed [2, 3] in relation to the metabolism of glycogen
[4], it was believed to be limited to the regulation of this
single pathway. Far from being true, subsequent studies
have proven the universal use of phosphorylation in the
control of cellular metabolism, cell cycle transitions,
growth, differentiation and apoptosis. Enzymatic phos-
phorylation has proven to be the most rapid and versatile
reversible post-translational modification of proteins af-
fecting activity, localization, stability and protein-protein
interactions. Phosphorylation is controlled by protein ki-
nases, which transfer a phosphate group from the donor
ATP or GTP onto acceptor amino acids in the substrate
protein, and protein phosphatases that catalyze hydrolysis
of the phosphoester bond and release of free phosphate.
To facilitate understanding of the subject dealt with in
this review, I will first introduce the key structural fea-
tures of the protein kinase family and then discuss the
mechanisms controlling the activity of kinases involved
with the onset of mitosis. For a detailed account of ki-
nases involved in other aspects of mitosis, the reader is re-
ferred to specialized literature [5–7].
Protein kinase phylogeny and structure
Identification of the first kinases was followed by intense
work focused on the clarification of enzymatic proper-
ties. It was not until the mid-1970s, when techniques such
as cloning by homology and the polymerase chain reac-
tion (PCR) were introduced, that the incessant discovery
of novel members of the kinase family prompted the first
attempt of aligning the catalytic domain of 65 distinct eu-
karyotic protein kinases (ePKs) [8]. Although this pio-
neering work was carried out using a wordprocessor, it
nevertheless provided a first glimpse of the complexity of
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this family of enzymes and prompted attempts to estimate
its size [9]. The most recent kinase phylogenetic tree, ob-
tained with today’s sophisticated software, fully accounts
for the complexity of the protein kinase family and shows
that early predictions of the number of kinases present in
the genome were not too far off. Current classifications
encompass all protein kinases identified upon conclusion
of the first draft sequencing of the human genome, which
include 478 ePKs and about 40 aPKs (atypical protein ki-
nase) genes. PK genes account for ~2% of all human
genes.
ePKs are distinct from histidine kinases and other phos-
photransfer enzymes [10], share a conserved catalytic do-
main but greatly differ in the mechanisms controlling ac-
tivity. Conversely, aPKs present no obvious similarity to
the ePK catalytic domain that would allow their annota-
tion as protein kinases [11], but possess kinase activity
that can be demonstrated in biochemical assays. The most
recent classification of protein kinases, which is still
based on the comparison of catalytic domains, yielded
nine major groups, 134 families and 189 subfamilies
[11]. Most of the kinase families found in the genome of
Homo sapiens are also present in other metazoans such as
yeast, worm and fly. Human kinases are, however, twice
as many as in the fly or worms [12]. The higher complex-
ity of the human kinome is accounted for by expansion of
families whose members control processes that are more
developed in higher metazoans, such as haematopoiesis,
angiogenesis and immunity [12]. About 10% of all ePKs
were found to lack key residues involved with catalysis.
This led to the hypothesis that expression of inactive ki-
nases may either serve a scaffolding function or be in
place to regulate the activity of neighboring catalytic do-
mains in cis [11].
From a structural point of view, the ePK catalytic domain
comprises 12 sub-domains containing highly conserved
amino acid residues (Fig. 1a). All ePKs display a similar
fold which is reminiscent of the structure of a ribosome:
they consist of an N-terminal lobe, predominantly com-
posed of b-sheets and one single a-helix called the C-he-
lix, and a larger C-terminal region that is essentially
made up of a-helices [13] (Fig. 1b). The amino-terminal
lobe encompasses subdomains I–IV, whereas the car-
boxy-terminal lobe contains subdomains VI–XI (Fig.
1a). The interface between the two lobes forms a deep
cleft which accommodates ATP [13] (Fig. 1b). Bound
ATP is capped by a glycine-rich motif called phosphate
loop or P-loop, located in subdomain I and displaying
the conserved motif GXGXFG, where F is in most cases
a hydrophobic amino acid [8]. Access to the ATP-bind-
ing site in many kinases is obstructed by a peptide that is
located between the conserved motifs DFG and APE in
subdomains VII and VIII (Fig. 1a). This region is called
the activation segment, is generally 20–30 residues in
length and contains one or two sites of phosphorylation
that are critical for activation in many kinases [13].
Structural studies have shown that in most kinases, phos-
phorylation of the activation segment leads to reposi-
tioning of this loop, which, as result, assumes an ex-
tended conformation and can interact with the substrate
[14] (Fig. 1b). Mechanistically, the conformational change
that stretches the activation segment is facilitated by ion-
pairing between the phosphorylated residue in the acti-
vation segment and an arginine that in many cases
precedes the catalytic aspartate in subdomain VIb (RD
di-peptide) [15] (Fig. 1a). In addition to a role in reposi-
tioning the activation segment, such interaction was pro-
posed to neutralize the arginine’s positive charge that
would otherwise hamper catalysis by the neighboring as-
partate [13, 14]. Structurally, the activation segment
comprises three elements, the Mg++-binding loop, the ac-
tivation loop and the P+1 loop [16] (Fig. 1a). The first is
involved in chelating the Mg++-ATP complex, whereas
the second physically contains the site(s) of regulatory
phosphorylation. The sequence of amino acids flanking
the activation loop normally defines the consensus for
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Figure 1. Structure of protein kinases’ catalytic domain. (a) The
core catalytic domain of protein kinases encompasses 12 subdo-
mains I–IV and VI–XI, participate in the formation of the bi-lobate
structure of protein kinases. Conserved residues in the P-loop and
in the activation segment are shown. The asterisk represents the po-
sition of residue(s) in the activation segment the phosphorylation of
which triggers kinase activation (see text for the details). Mg++-BL,
Mg++- binding loop; AL, activation loop; P+1L, P+1 loop. (b) 3D
structure of Aurora A catalytic domain (PBD ID: 1MQ4 [191]). The
ATP bound in the deep cleft between N- and C-terminal lobes and
the residue phosphorylated in the activation segment are shown.
recognition of this particular loop and ensuing phospho-
rylation by upstream kinase(s). In addition to its role in
the process of kinase activation, the activation loop has
been shown to be involved in a less-explored but equally
important mechanism: this is the interaction with pro-
teins that affects the localization and activity of a protein
kinase [17]. Finally, the P+1 loop located at the extreme
C-terminus of the activation segment has a critical func-
tion in substrate binding. This loop was named after its
ability of contacting the P+1 residue in the peptide in-
hibitor PKI bound to protein kinase A (PKA), though it
is now evident that the P+1 loop interacts with additional
neighboring residues [16]. The primary structure of re-
gions located outside the catalytic domain of serine/thre-
onine kinases varies extremely and encompasses do-
mains involved in regulatory functions, protein-protein
interaction modules and motifs controlling subcellular
localization [10, 11].
Mitosis
The first description of a cell was made by the English
physicist Robert Hooke (1635–1702), who observed the
structure of cork slices with one of the early micro-
scopes [18]. In 1838 and 1839, two German scientists,
the botanist Matthias Jakob Schleiden (1804–1881) and
the physiologist Theodor Schwann (1810–1882), pro-
posed that cells are the basic units of all organisms and
that the nucleus may have an important role in the gen-
esis of cells, although the latter concept was not cor-
rectly formulated. In 1852 the eminent pathologist
Robert Remak (1815–1865), reporting his observations
on frog eggs, concluded that cleavage is due to a contin-
uous process of division that always begins with the nu-
cleus. In 1858 Rudolf Virchow (1821–1902) formally
formulated the principle that every cell derives from
a pre-existing cell: ‘omnis cellula e cellula’. Finally,
Theodor Boveri (1862–1915), working on the eggs of
Ascaris megalocephala, a parasitic worm containing
only four chromosomes, was the first to describe the be-
havior of chromosomes during cell division [19] (see
also: http://www.laskerfoundation.org/news/gnn/time-
line/). Thanks to the identification of suitable model or-
ganisms and with the help of modern technology, we
have now reached a deep understanding of mechanistic
aspects and regulatory pathways controlling the onset,
execution and completion of mitosis [20]. According
to the current view, mitosis is composed of five phases:
prophase, prometaphase, metaphase, anaphase and telo-
phase. Upon completion of DNA replication, sister
chromatids are held together at the centromeric region
by structures called kinetochores and are catenated
through their entire length by cohesins [21]. The first
event clearly visible in prophase nuclei is chromatin con-
densation, which allows reducing the length of un-
condensed DNA to an extent compatible with the
distance that chromatids cover when moving to the op-
posite poles of the mitotic spindle [22]. Chromatin
condensation requires the combined action of a multi-
subunit protein complex named condensin and of topo-
isomerase II, the latter being involved in the decatena-
tion of sister chromatids [22]. Chromatin condensation
coincides with phosphorylation of histone H3, a process
that depends on the activity of the kinase Aurora B (see
below). In late prophase, the microtubuli that formed
the interphase cytoskeleton are disassembled, and highly
dynamic microtubules radiate from centrosomes. These
mitotic microtubules drive the migration of separated
centrosomes, each with its pair of centrioles, to the op-
posite poles of the cell. Nuclear envelope breakdown,
which is facilitated by phosphorylation of lamins, en-
sues at the time of transition to prometaphase. At this
point, spindle microtubules enter the nucleus and make
contact with kinetchores that are located on each chro-
matid and face to opposite directions. As the cell
approaches metaphase, chromosomes congress to the
equator of the spindle where they are aligned to form the
so-called metaphase plate. This process may require a
substantial amount of time, since complete assembly of
the mitotic spindle implies that all kinetochores attach
to fibers that have nucleated from the two opposite cen-
trosomes (a process called bi-orientation). At anaphase,
the movement of chromatids to the poles of the spindle
results from shortening of the microtubules that are at-
tached to kinetochores. At the molecular level, the sep-
aration of chromatids is facilitated by anaphase-promot-
ing-complex/cyclosome (APC/C)-driven degradation of
cohesin [23]. Concomitant with disassembly of kineto-
chore microtubules, the elongation of polar micro-
tubules contributes to push the spindle poles aside. The
process is concluded by re-establishment of the nuclear
membrane around decondensing chromosomes at telo-
phase and is followed by physical separation of the two
daughter cells, or cytokinesis [24].
Cyclin-dependent kinase 1
The prototype cyclin-dependent kinase Cdc2, now known
as Cdk1, belongs to the CMCG group [11] and was dis-
covered through convergence of genetic and biochemical
studies. Paul Nurse, studying the cell division cycle in
yeast, identified genes exerting cell size control at nu-
clear division [25]. Biochemical investigations carried
out on amphibian oocytes a few years earlier [26, 27] led
to the identification of MPF, or maturation-promoting
factor, a factor that was shown to facilitate entry into
mitosis and meiosis. In 1988, working with Xenopus
oocytes, Lohka and co-workers successfully purified
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MPF [28], which turned out to be composed of Cdk1 [29–
32] and a B-type Cyclin [33, 34]. The Cdk1 protein is
constantly present throughout the cell division cycle, but
its activity is finely tuned by means of protein-protein in-
teractions and reversible phosphorylation [35]. The two
regulatory partners of Cdk1 are Cyclin A and Cyclin B,
which are encoded by genes that are under cell cycle-de-
pendent transcriptional control [36, 37]. Prior to cyclin
binding, Cdks are in an inactive conformation with the C-
helix of the small lobe (also called PSTAIRE after its pri-
mary sequence) pointing outward, in a position that
excludes the last residue of the helix, the catalytic E51,
from the active site [38]. Interaction with cyclin occurs
over a large surface and facilitates repositioning of the
PSTAIRE helix in a way that brings E51 in close proxim-
ity to K33, the residue that coordinates ATP. Such confor-
mational modification is, however, not sufficient to con-
fer full activation on Cdk. Rather, activation results from
phosphorylation of a residue in the activation loop (T161
or T160 in Cdk1 or Cdk2, respectively) by an upstream ki-
nase known as Cdk-activating kinase (Cak) [39, 40].
Phosphorylation at this residue is cell cycle-regulated in
a manner that parallels the pattern of cyclin binding [41]
and results in ion-pairing of the T-loop T161 with R128, a
residue that precedes the catalytic D129. This interaction
neutralizes the positive charge of R128 and facilitates
repositioning of the activation loop that allows now bind-
ing of the substrate (see above) [13]. Cdk1 isoforms lack-
ing most of the T-loop are present in breast cancer cells
but not in normal fibroblasts and lymphocytes [42]. T-
loop deletion mutants were reported to be unable to inter-
act with cyclin B1 and displayed no kinase activity, thus
pointing to the important function of the T-loop in pro-
tein-protein interaction in addition to its role in facilitat-
ing catalysis [42]. 
A second layer of control on Cdk1 activity is exerted by
signals delivered by the machinery that detects comple-
tion of DNA synthesis and/or successful repair of dam-
aged DNA (Fig. 2). Such signals converge on the ki-
nases Wee-1 and Myt1 that inhibit Cdk1 kinase activity
through phosphorylation of two residues, Thr14 and
Tyr15, in the Gly-rich P-loop. Initial studies led to the
proposal that phosphorylation at these sites would im-
pair ATP binding, either sterically and/or by electrosta-
tic repulsion [43]. However, a later assessment of the
mechanism of Cdk1 inhibition revealed that phosphory-
lation at these sites did not affect nucleotide binding but
rather hampered catalysis [44]. Thr14 and Tyr15 are de-
phosphorylated by the dual-specificity phosphatase
Cdc25C [45], the activity of which increases during mi-
tosis and is triggered through Cdk1- [46] and Polo-like
kinase 1-dependent phosphorylation [47] (Fig. 2). A
mechanistic model accounting for the effect of phos-
phorylation of P-loop residues on the inhibition of cat-
alytic activity was formulated upon resolution of Cdk2
crystal structure [48]. According to the latter, the hy-
droxyl group of Thr14 and Tyr15 point inward the ATP-
binding site in a manner that brings them in close prox-
imity to ATP, particularly in the case of Thr14. In Cdk2,
the phosphates of ATP are normally held in place by in-
teraction with a number of residues involved with catal-
ysis, among which Lys33 and Asp145, and backbone
amides of the P-loop [48]. Phosphorylation of P-loop
residues was suggested to disrupt the conformation of
the phosphates of ATP and, as such, impair catalysis
[48]. Given the high homology between Cdk2 and
Cdk1, the model is likely extendable to the latter.
The influence of Cdk1 on mitotic entry has been estab-
lished through genetic studies in model organisms [49–
53], microinjection experiments [54, 55], expression of a
dominant-negative mutant isoform [56], induced expres-
sion of cyclin-dependent-kinase inhibitors (CKI) [57,
58] and the use of chemical inhibitors (reviewed in [59])
and have been extensively reviewed elsewhere [60]. The
mechanisms through which Cdk1 promotes entry and
transition through mitosis are multiple and are mediated
by phosphorylation of numerous substrates. These in-
clude lamins, the phosphorylation of which leads to nu-
clear membrane breakdown [61], microtubule-associ-
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Figure 2. The G2/M DNA damage checkpoint. Detection of dou-
ble-strand breaks in DNA by protein complexes (depicted in grey)
sensing damage is followed by initial processing of the lesions.
This generates structures that trigger DNA damage checkpoints.
The G2/M checkpoint controls key components of the mitotic ma-
chinery such as Cdk1, Plk1 and AurA and results in arrest before
the onset of mitosis. Hyperactivation of oncogenes such as AurA
(indicated by a star) may facilitate bypass of the checkpoint in the
presence of unrepaired damage, whereas reactivation of Plk1
through an as yet unknown mechanism (indicated by a question
mark) may contribute to DNA damage recovery. Solid lines repre-
sent established control mechanisms, whereas dotted lines indicate
hypothetical links.
ated proteins and kinesin-related motor proteins, which
participate in centrosome separation and assembly of the
mitotic spindle [62], and proteins that control chromo-
some condensation such as condensins [63]. In addition
to the supervision of mechanistic aspects of mitosis,
Cdk1 fulfills a regulatory function through the control of
the anaphase-promoting-complex/cyclosome (APC/C)
[64, 66], a protein destruction machinery that sets the
timing of transition through and exit from mitosis by de-
grading cyclins, Polo-like kinase 1, Aurora-A and -B,
Nek2, securin and Cdc20 among others (reviewed in
[67]).
Polo-like kinase 1
Polo-like kinase 1 (Plk1) was initially identified in Dro-
sophila as a kinase the mutation of which led to the for-
mation of abnormal spindles [68]. The same phenotype
was observed in yeast upon deletion of the Saccha-
romyces cerevisiae homologue (CDC5) [69]. Vertebrates
express three to four members of the Polo family of ki-
nases (reviewed in [70]), with Plk1 being the most exten-
sively investigated component. Structurally, Plk1 is char-
acterized by an N-terminal catalytic domain, a central
destruction motif (D-box) and two polo box domains
(PBDs) at the C-terminus. The PBD is capable of recog-
nizing and binding phosphorylated residues in the con-
text S-pS/pT-P/X [71], thus allowing Plk1 to dock to pro-
teins that are in turn phosphorylated by Plk1. Considering
that the consensus for PBD binding fulfills the require-
ments for phosphorylation by Proline-directed kinases
such as Cdks and MAP kinases, it has been suggested that
the latter may act as priming factors for Plk1 targeting
[70].
The PBD has two established functions: it constitutes an
autoinhibitory domain [72] whose negative role is re-
lieved through phosphorylation at the T-loop site T210 [73]
(see below), and it plays an important role in Plk1 sub-
cellular localization [74]. The latter was elucidated in
complementation studies conducted on the temperature-
sensitive cdc5-1 mutant yeast strain, where mutation of
conserved residues in the PBD disrupted localization and
mitotic functions of human Plk1, without nonetheless al-
tering catalytic activity [75]. As support to this conclu-
sion, evidence obtained by impairing PDB-mediated
binding of Plk1 to its targets via introduction of compet-
ing phosphopeptides in cells, prevented Plk1 localization
at centrosomes [71].
The S. cerevisiae Cdc5p and the mammalian homologue
Plk1 are principally expressed in G2 and M phase [76,
77]. As for Cdc5p, activation of human and Xenopus
Plk1 involves phosphorylation at two residues, one of
which is located in the activation loop [78, 79]. Muta-
tion of both sites to acidic amino acids in Xenopus Plk1
was shown to increase catalytic activity severalfold.
Moreover, microinjection of Xenopus oocytes with the
messenger RNA (mRNA) encoding this double point
mutant led to direct activation of Cdc25C and Cyclin B-
Cdk1 [79]. Along with additional biochemical evidence,
these data were taken as support to the concept that Plk1
is the trigger of Cdc25C activation [79]. Studies con-
ducted on HeLa cells reached slightly different conclu-
sions on the importance of the two sites of phosphoryla-
tion in Plk1, in that they demonstrated that the key acti-
vating event is phosphorylation of the T-loop residue,
and this correlates with entry into mitosis. The authors
suggested that phosphorylation at the second site is
likely limited to other stages of the cell cycle [80]. The
kinase responsible for Plk1 phosphorylation at the T-
loop residue was initially suggested to be Xenopus
Plkk1 [81], which is the homologue of human Slk. How-
ever, recent reassessment of this issue led to the conclu-
sion that rather than being an upstream activating ki-
nase, Plkk1 may be a target of Plk1 at the G2/M transi-
tion [82], thus leaving the issue of the mechanism of
Plk1 activation still open. The close similarity of the
amino acid sequence around the Plk1 T-loop site to the
consensus for PDK1 led others to speculate that the lat-
ter may be a Plk1-kinase [83], though in vivo and/or in
vitro evidence to support this hypothesis is not available.
The identity of the kinase responsible for in vivo phos-
phorylation of the second site described in the literature
(S137 in human Plk1) is as yet unknown.
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Table 1. Protein kinases controlling the onset and progression
through mitosis.
Protein Function References
kinase
Cdk1 nuclear membrane breakdown, mitotic 27–33; 44–61
spindle assembly, chromosome conden-
sation, APC/C regulation  
Plk1 centrosome maturation, microtubules 79–92
dynamics, chromosome segregation, 
APC/C regulation, DNA damage recov-
ery
Nek2 centrosome splitting 102–105 
AurA centrosome separation, Cdk1/Cyclin B1 110, 116 
activation 
AurB chromosomes condensation, chromo- 128, 144–150 
somes bi-orientation, cytokinesis 
Mps1 centrosome duplication and separation, 192 
chromatide-spindle attachment 
PKA APC/C regulation 154 
PKC mitotic progression 157 
PI3K cyclin B1 expression 163 
Akt/PKB G2/M checkpoint bypass 161, 165 
Cdc5p and Plk1 localize at centrosomes in early mitosis,
redistribute to the spindle and mitotic bridge at anaphase
[77] and are rapidly degraded by the APC/C-Cdh1 during
exit from mitosis [76, 84, 85]. Whereas the Cdc5p degra-
dation motif is localized at the N-terminus, Plk1 destruc-
tion depends on a D-box that is located in the central part
of the protein [86]. The many functions of Plk1 at mitosis
[87] are well accounted for by the variety of substrates so
far identified for this kinase. These consist of proteins in-
volved with chromosome segregation, such as cohesin
[88], microtubules dynamics [89] and nucleation [90] as
well as cytokinesis [91]. In addition to the regulation of
mechanistic aspects of mitosis, Plk1 contributes to set the
timing of entry and transition through mitosis by phos-
phorylating APC/C subunits [92, 93]. Another interesting
control mechanism in which members of the Polo kinase
family are involved is the control of mitosis in response
to DNA damage (Fig. 2). When DNA damage occurs af-
ter replication (i.e., in G2), cells normally remain arrested
for a limited period of time, after which they display
‘adaptation’ to damage. This response, which was ini-
tially observed in yeast and more recently described in
Xenopus [94], consists in increased tolerance to DNA
damage and results in the progression into the next phase
of the cell cycle (i.e., G1) where repair is attempted [95].
Contrary to adaptation, ‘recovery’, which follows the
successful repair of damage, is accompanied by down-
regulation of DNA damage response pathways and re-
sumption of cell cycle progression. An S. cerevisiae
CDC5 mutant was found to be adaptation-defective, and
cells of this strain remained permanently arrested with
large buds when irreparable DSB occurred in the genome
[96]. This evidence prompted the search for a parallel re-
sponse in human cells. Inhibition of Plk1 activity was in-
deed observed upon induction of DNA damage in G2
[97] or in M-phase [98]. Whereas in the first setting Plk1
inhibition was reported to be ATM- or ATR-dependent
[99], DNA damage caused in M-phase led to Plk1 inhibi-
tion through dephosphorylation, and this effect was
ATM-independent [98]. Considering that Plk1 does not
contain consensus sequences for phosphorylation by
ATM or ATR, it can be ruled out that Plk1 may serve as
direct substrate for these DNA damage sensors (Fig. 2).
On the other hand, the presence of potential phosphoryla-
tion sites for Chk1 or Chk2 suggests that Plk1 may be tar-
geted by checkpoint kinases [100], an issue that has not
been explored to date. In line with the evidence obtained
in yeast, subsequent studies addressed the role of Plk1
during recovery from DNA damage [101]. Since the
mechanism of recovery from DNA damage is still not
fully understood in its molecular details, in the study con-
ducted on human cells [101] recovery was mimicked by
interrupting the flow of DNA damage signals with the
ATM/ATR inhibitor caffeine. In this setting, Plk1 was
shown to facilitate resumption of cell cycle progression
and mitotic entry. At the molecular level, this occurred
through phosphorylation-dependent degradation of Wee1
(Fig. 2), which together with Myt1 [102] is a known Plk1
substrate [103]. However, as for the report on Plk1 inhi-
bition by DNA damage, both the pathway and the molec-
ular mechanism supporting reactivation of DNA damage-
inhibited Plk1 during recovery remain to be clarified (see
also below).
Nek2
Nek2 is a mammalian serine/threonine protein kinase dis-
playing high sequence homology to NIMA, a kinase nec-
essary for entry into mitosis in the filamentous fungus As-
pergillus nidulans [104]. Nek2 is a 48-kDa protein com-
prising 445 residues with a catalytic domain localized at
the N-terminus of the molecule and a regulatory domain
at the C-terminus. Two regions predicted to fold as coiled-
coils, with one of them displaying similarity to Leu-zip-
pers, are present within the regulatory domain [105].
The mechanism of Nek2 activation has been only par-
tially explored. It appears that homodimerization
through the unusual Leu-zipper coiled-coil motif facili-
tates autophosphorylation in trans, and this results in en-
zymatic activation [106]. Autophosphorylation, though,
may not be the only mode of kinase activation. A study
investigating meiotic progression in mouse spermato-
cytes showed that the MAPK/p90Rsk2 pathway was re-
quired to control Nek2 activation and that the latter was
an in vitro substrate for p90Rsk2 [107]. The reported stoi-
chiometric interaction of Nek2 with protein phosphatase
1 [108] may add a further layer of complexity to the reg-
ulation of Nek2 kinase activity, as was observed in the
case of AurA (see below). Nek2 protein level is low in
G1 and increases throughout S and G2 [109]. The protein
is rapidly degraded at the pro-metaphase to metaphase
transition of mitosis in an APC/C-Cdc20-dependent
manner and with kinetics similar to Cyclin A [110].
Nek2 is a centrosomal resident protein that upon overex-
pression causes centrosome splitting [111], an event that
is different from the physiological separation of centro-
somes occurring at G2/M. In the case of centrosome
splitting induced by overexpressed Nek2, mother and
daughter centrioles appear to be separated by > 2 mm,
though this is not followed by recruitment of motor pro-
teins at centrosomes and assembly of a functional mitotic
spindle [112]. Nek2-driven centrosome splitting is likely
accomplished through phosphorylation of C-Nap1, a
protein interacting with Nek2 and associated with the
proximal ends of mother and daughter centrioles [113,
114].
The possible inhibition of Nek2 as contribution to the cell
cycle arrest that follows damage to DNA has been ad-
dressed by a single study. The authors claimed that both
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kinase activity and Nek2 protein level were reduced upon
DNA damage [115]. However, a note of caution should be
added here, since rapid reduction of the transcription rate
of genes encoding mitotic regulators is a known conse-
quence of DNA damage [116] and may not be a specific
Nek2 response.
The Aurora kinases
The Aurora kinases belong to a family of mitotic protein
kinases that regulate centrosomal and microtubule activ-
ity, thus controlling the accuracy of chromosome segre-
gation and cytokinesis [117]. Aurora proteins were first
described in S. cerevisiae and Drosophila. One single
form of the kinase, Ipl1, is expressed in yeast [118],
whereas two members of the family are present in
Drosophila (Aurora and IAL) [119] and at least three in
mammals (Aurora A-C) [60]. Budding yeast Ipl1 mu-
tants display abnormal ploidy [120]. Drosophila Aurora
mutants typically display monopolar spindles as a result
of defective centrosome separation [119]. Of the three
human homologues so far described [117], AurA and
AurB were isolated by means of degenerate oligo-based
PCR [121], and in a screening for kinases overexpressed
in colon carcinoma [122]. AurA is a nuclear protein that
re-localizes to the centrosomes in late S and G2 and to
the spindle throughout mitosis [123, 124]. Depletion of
AurA by small interfering RNA (siRNA) in HeLa cells
results in an almost complete block of entry into mitosis
[125], whereas overexpression of AurA causes transfor-
mation of Rat1 and NIH3T3 cells, which in turn can
grow as tumors in nude mice [122]. Studies of the po-
tential role of AurA in carcinogenesis have described the
frequent amplification of AurA gene in human tumors
and cancer cell lines as well as the high expression of
AurA mRNA in a manner independent of gene amplifi-
cation [122, 126, 127].
The three mammalian Aurora members display a con-
served catalytic core, which is flanked by N- and C-ter-
minal domains containing regulatory motifs [128].
Among these is an N-terminal K-E-N motif, which is
commonly the site of ubiquitinylation of APC/C-Cdh1
target proteins that are degraded at mitotic exit and early
G1 [67]. However, deletion [129] or point mutation
analysis [130] showed that the K-E-N motif is not re-
quired for AurA destruction. A silent C-terminal de-
struction box (D-box), similar to that found in cyclin B,
is present in all members of the family. Contrary to AurB
and AurC, however, AurA D-box is rendered functional
by the presence of an N-terminal A-box (also known as
D-box Activating Domain, DAD) [130, 131]. The A-box
of Xenopus AurA encompasses a site, Ser53, the phos-
phorylation of which results in stabilization of the kinase
[130, 132].
The mechanism of enzymatic activation has been ad-
dressed in detail for AurA. AurA activation requires
phosphorylation at a number of sites [132], among which
the T-loop residue (T288 in human AurA) seems to be a key
determinant. PKA was initially claimed to be responsible
for phosphorylation at T288 [133]. However, a recent re-
assessment of this issue where inhibitors and physiologi-
cal activators of the cyclic AMP (cAMP)-dependent ki-
nase were employed, ruled out the latter as upstream
AurA-kinase [134]. In addition, the fact that the cAMP
level, and consequently protein kinase A activity, de-
crease as cells approach mitosis [135] (see also below),
leaves groundless any argument in favor of PKA. The ev-
idence so far indicates that phosphorylation at T288 is the
result of an autocatalytic event likely driven by clustering
of AurA molecules [134, 136]. Arguments in favor of this
hypothesis derive from studies on recombinant AurA as
well as from in vitro reconstitution experiments. In bacte-
ria, which notably contain no serine/threonine protein ki-
nases, expression of Xenopus [136] or human [134, 137]
recombinant AurA yields a kinase that is phosphorylated
at multiple sites [134, 136], likely through an autocat-
alytic process, and is highly active. On the other hand, the
lower degree of activity displayed by recombinant Xeno-
pus AurA expressed in insect cells [132], and the fact that
such activity can be boosted by treating cells with
okadaic acid [132], indicates that in eukaryotic systems
additional factors contribute to the control of AurA activ-
ity, as exemplified by the functional interaction with pro-
tein phosphatase 1 (see below). Xenopus AurA expressed
in bacteria displayed stoichiometric phosphorylation at
T295 [136], the T-loop site equivalent to T288 in human
AurA. A recent study on human recombinant AurA pro-
vided the rationale for this observation. The authors
showed that T288 is the only site in the kinase flanked by a
sequence perfectly fitting the consensus for substrate
phosphorylation by AurA [134]. In addition to autophos-
phorylation as a possible mechanism for AurA activation,
in a recent report it was demonstrated that the small GT-
Pase-activated kinase Pak1 is able to efficiently bind to
inactive AurA and phosphorylate two of the three mitotic
sites described in AurA, namely the T-loop T288 and the
more downstream site S342 [138]. Although the Authors
were unable to show that known kinases present at cen-
trosomes could activate Pak1, leaving thus open the
search for upstream regulators of the cascade impinging
on AurA, this study represents an important step in the re-
construction of the pathway upstream of AurA. Biochem-
ical studies attempting in vitro reconstitution of the AurA
activation system using Xenopus eggs extracts identified
the motor-binding protein TPX2 (Targeting Protein for
Xenopus kinesin-like protein-2) as an in vitro activator of
AurA [139]. TPX2, which is normally localized to the nu-
cleus through active shuttling by Importin-b, is released
in a Ran-GTP-dependent manner as cells approach mito-
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sis and drives localization of AurA at centrosomes [140].
This would be consistent with observations made in vitro,
in that close proximity of AurA molecules facilitates au-
tophosphorylation and kinase activation. Structural stud-
ies where AurA and TPX2 were co-crystallized, con-
firmed the key role played by TPX2 in maintaining the
phosphorylated T288 residue in a buried position where it
is protected from dephosphorylation, thus locking AurA
in an active conformation [141].
The catalytic domain of AurA contains two R/K-V-X-F
motifs that have been implicated in binding protein phos-
phatase 1 (PP1) in a functional manner [142]. Although
the mechanism of mutual control of PP1 and AurA has
not been dissected at the molecular level, as postulated
for the Nek2-PP1 interaction [108], the activating reac-
tions of AurA autophosphorylation and PP1 autodephos-
phorylation compete with the opposite (inhibitory) re-
actions resulting in reciprocal regulation of enzymatic
activity [142]. However, how the balance of these com-
peting reactions is tilted to one or the other side during
progression to mitosis is still unclear. The observation
that treatment of cells with the PP1 inhibitor okadaic acid
leads to hyperactivation of AurA [132], likely by prevent-
ing T288 dephosphorylation, supports the idea of an in-
hibitory role for PP1. This simple interpretation, however,
is invalidated by evidence that AurA mutants unable to
bind PP1 are enzymatically inactive [142]. Therefore, it
appears that in addition to phosphatase activity, PP1 bind-
ing per se has a role in controlling AurA activity. Another
twist to the story was brought by the evidence that the
PP1 inhibitor-2 protein (I-2) behaves as allosteric activa-
tor of AurA in vitro, in a manner similar but not additive
to TPX2 [143]. In this study it was demonstrated that the
effect of I-2 on AurA was independent of inhibition of
PP1 activity. Among other proteins interacting with AurA
is AIP, which affects AurA protein level through protea-
some-dependent degradation [144], and the LIM-protein
Ajuba, which behaves like an AurA allosteric activator
[125]. TPX2 and Ajuba are phosphorylated by AurA, and
the list of current AurA substrates includes the kinesin-
like protein Eg5 [117], the Cdc25B phosphatase [145],
BRCA1 [146] and p53 [147].
As for CDK1 and Plk1, the activity of AurA is also in-
hibited in response to genotoxic damage [124, 148]. The
pathway relaying DNA damage signals to AurA depends
on CHK1 and results in phosphorylation of AurA at the
inhibitory site S342 [124] (Fig. 2). An interesting issue is
whether mitotic kinases are inhibited by DNA damage
signals in parallel or in series. Addressing this question
requires a careful experimental setting allowing coordi-
nated introduction of an active form of the kinase under
investigation in DNA damaged cells and monitoring of
progression through mitosis. To this end, transient or sta-
ble expression of a kinase is not a suitable approach,
given two major drawbacks: (i) the excessive production
of recombinant protein in the case of continuous expres-
sion and (ii) the slow kinetic of protein expression in the
case of inducible constructs, which is incompatible with
the rapid sequence of events at mitosis. The correct ex-
perimental setting was identified in a recent study on
AurA where physiological amounts of purified and
highly active AurA protein were transduced in DNA
damaged cells precisely after induction of damage in G2-
synchronized cells [124]. The authors could show that
this approach resulted in bypass of the G2 DNA damage
checkpoint and progression to mitosis, and this was char-
acterized by reactivation of DNA damage-inhibited
Cdk1. Considering that Cdk1 is not a substrate for AurA,
it must be inferred that AurA controls Cdk1 through
the upstream regulators Cdc25B or Wee1/Myt1 [124]
(Fig. 2).
As for AurA, the AurB protein level is cell cycle regu-
lated. AurB kinase activity peaks after AurA and follow-
ing the inactivation of Cdk1 [122], though this is not
linked to the triggering of AurB activity. AurB is a chro-
mosomal passenger protein which relocalizes at the mid-
zone of anaphase cells and at the post-mitotic bridge
of telophase cells [128, 149]. AurB is activated by
autophosphorylation at the T-loop residue T232 [150] upon
interaction with the inner centromere protein INCENP
[151] [152]. Ectopic expression of kinase inactive AurB
results in the appearance of multinucleated cells, a phe-
notype that has been attributed to a defect in the final step
of cytokinesis [153]. RNA interference studies on
Drosophila AurB confirmed the occurrence of chromo-
some condensation and segregation defects followed by
failure at cytokinesis [154]. Such a variety of effects may
find a ground in the multiplicity of pathways affected by
AurB. AurB has been described as a kinase capable of
phosphorylating Ser10 and Ser28 in histone H3 [137, 154–
156]. Ser10 phosphorylation starts at the pericentromeric
region in G2, spreads through the entire length of chro-
mosomes by metaphase [157] and is required for initia-
tion, but not maintenance, of mammalian chromosome
condensation [158]. Although Histone H3 phosphoryla-
tion by AurB is not sufficient per se to trigger chromo-
some condensation, it was recently demonstrated to be a
dynamic way to mark chromatin that results in the release
of HP1 at M phase [159, 160]. HP1 is a protein that asso-
ciates to H3 in interphase through methylated Lys9 and
plays a role in the architecture of chromatin. The role of
AurB-dependent H3 phosphorylation is underscored by
the fact that vertebrate cells functionally deficient in
AurB fail in condensing chromosomes, in addition to dis-
playing defective alignment and segregation of chromo-
somes [161, 162]. Moreover, defective AurB-dependent
phosphorylation of MCAK (mitotic centromere-associ-
ated kinesin) [163–165] may relate to the inability of cor-
recting improper kinetochore attachment during chromo-
some bi-orientation (see above). Finally, lack of phospho-
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rylation of another AurB substrate, the filament protein
vimentin [166] that is involved in shaping the cleavage
furrow at cytokinesis, results in cytokinesis failure.
Other protein kinases affecting the onset of mitosis
A number of studies have pointed to a role for other pro-
tein kinases in the control of mitosis, though only in some
cases the analysis was sufficiently complete to allow a fi-
nal statement of their importance. It is, nevertheless,
worth mentioning these data, as they may prompt novel
studies reassessing and eventually expanding the initial
findings. Most of the kinases listed below were initially
identified and characterized in a cell cycle-independent
context, and only later was their involvement in cell cycle
transitions examined.
Early studies on HeLa cells showed that the concentration
of the second messenger and PKA activator cAMP is low
at mitosis and high in late G1 and early S-phase [167].
Moreover, it was reported that artificial elevation of
cAMP levels in S or G2 caused G2 arrest and lengthening
of M-phase. In contrast, addition of cAMP analogues at
metaphase had the opposite effect, resulting in an acceler-
ated exit from mitosis [167]. Similar data were obtained in
yeast [168]. Analysis of Xenopus eggs confirmed that the
minimum level of cAMP was observed at the onset of mi-
tosis and this was followed by an increase in the cyclic nu-
cleotide at the mitosis-interphase transition [169]. More-
over, blocking the activation of PKA at metaphase was
shown to prevent transition through mitosis [135]. Light
was shed in part on the molecular mechanism underlying
these effects by the finding that PKA is responsible for
phosphorylation and inhibition of components of the 20S
complex at the onset of mitosis [170]. The 20S complex,
also known as APC/C, is required for the destruction of
mitotic cyclins and for the separation of sister chromatids
at the anaphase-to-metaphase transition [67]. The correct
timing of APC/C activation at metaphase is apparently
controlled by positive phosphorylation resulting from the
increasing activity of Plk1 and by protein phosphatase 1
(PP1)-mediated [171] dephosphorylation of inhibitory
sites that are targets of PKA [92].
Here, however, the reader should bear in mind that not all
effects of cAMP are mediated through the activation of
PKA [172]. Furthermore, considering that the consensus
sequence for substrate phosphorylation by PKA signifi-
cantly overlaps with that of many basophilic protein ki-
nases [173], genuine PKA substrates should only be de-
clared such upon converging in vitro and in vivo evidence,
possibly accompanied by genetic scrutiny of the pathway
in which PKA is hypothesized to play a role.
The yeast calcium and phospholipid-dependent protein
kinase (PKC1) was shown to be required for progression
to mitosis, with deletion mutants displaying a G2 arrest
characteristic of cell division cycle mutants [174]. Stud-
ies on mammalian cells confirmed these results, showing
an increase in the nuclear level of the PKC activator dia-
cyclglycerol at G2/M [175], an event that would facilitate
triggering of PKC-mediated phosphorylation of proteins
involved with mitosis such as vimentin [176], lamin A
[177] or lamin B [175].
Perhaps one of the most interesting kinase cascades
shown to play a role at the G2/M transition is the phos-
phoinositide 3 kinase (PI3K)/3¢-phosphoinositide-depen-
dent kinase 1 (PDK1)/protein kinase B (Akt/PKB) path-
way. Studies on MDCK cells showed that Akt/PKB activ-
ity is high at G2/M and that the cell cycle block imposed
by inhibitors of PI3K could be bypassed by expression of
constitutive active Akt/PKB mutants [178]. Other studies
based on the use of cell-permeable inhibitors and domi-
nant-negative mutants concluded that the PI3K pathway
is activated prior to completion of DNA synthesis [179]
and contributes to cyclin B1 expression and Cdk1 activa-
tion [180]. Accordingly, expression of a constitutively ac-
tive form of PI3K was reported to delay mitotic exit due
to defective cytokinesis, and these effects were attributed
to altered phosphorylation of the Akt/PKB substrates
forkhead-transcription factors [181]. An intriguing func-
tion of Akt/PKB is its role in mediating bypass of the G2/
M checkpoint activated in response to genotoxic damage
[182], which stems, at least in part, from the ability of
Akt/PKB to mitigate DNA damage-dependent inhibition
of Cdk1 [182]. The molecular mechanism underlying re-
sistance of Cdk1 to inhibition by genotoxic agents in cells
expressing activated Akt/PKB is not known, though evi-
dence that Akt/PKB-dependent phosphorylation of Chk1
at S280 renders the latter apparently refractive to activation
by ATM/ATR may provide an answer [183]. Considering
that phosphorylation-dependent inhibition of the E3 lig-
ase responsible for Plk1 degradation is controlled by Akt/
PKB and results in stabilization and reactivation of Plk1
[184], and this is eventually necessary to recover from
DNA damage [101], this could represent another level
at which Akt/PKB participates in reinforcing the loop con-
trolling Cdk1 activity [185]. Indirect support to this comes
from a study where depletion of Pdk1p (the Schizosac-
charomyces pombe homologue of human PDK1, an acti-
vating kinase upstream of Akt/PKB) resulted in defects
in mitosis and cytokinesis that were exacerbated by com-
promising the function of Plo1p, the fission yeast polo ki-
nase 1 [186].
Conclusions
Mitosis is an extraordinarily regulated process that results
in the segregation of sister chromatids into two newly
made cells. Early biochemical studies on cell division
have led to the identification of Cdk1 as the histone H1
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kinase with the highest specific activity in mitotic cells.
The evidence acquired since the discovery of Cdk1 has
exposed many of the pathways controlled by this kinase,
and this has earned Cdk1 the designation of ‘master mi-
totic regulator’. Although Cdk1 remains the undisputed
central controller of mitosis, recent investigations have
expanded our understanding of cell division by revealing
the presence of ancillary activities, such as those of Plk1,
NIMA and Aurora-related protein kinases, which are cru-
cial in setting the stage, lead to commitment to and fa-
cilitate the execution of mitosis. The discovery of cross-
talk between mitotic kinases, as is the case for the Aurora
A-dependent Cdk1 recruitment and activation at the cen-
trosome in G2 [125] or the regulation of Cdk1/Cyclin B1
nuclear localization by Plk1 at prophase [187], has shown
that further layers of control contribute to increase the
complexity of mitotic onset. Finally, the effect of ‘non-
canonical’ mitotic kinases in setting the stage for mitosis
through indirect control of Cdk1, the best example being
illustrated by the PI3K-Akt/PKB pathway, indicates that
reconsidering with an open mind kinase cascades that
have established roles in other phases of the cell cycle
will likely provide interesting surprises.
Clearly, what is sketched in this essay is only one side of
the coin, and the final picture of mitotic control will have
to take into account the opposite contribution of phos-
phorylation and dephosphorylation.
Perspectives
The evidence acquired to date on the role of phosphoryla-
tion should be sufficient to equate it to the relevance of
gravitation in physics and, thus, counter the skepticism of
those who did not initially acknowledge the importance of
phosphorylation in biology. It is expected that future re-
search will take advantage of large-scale proteomic analy-
sis to expose the full repertoire of post-translational mod-
ifications of mitotic protein kinases in specific, and of
proteins in general. This, in turn, will provide hints of how
the information stored in the relatively small pool of genes
present in our genome can give rise to the complexity of
the metabolic pathways that scientists are dissecting.
Thus, after having cracked the DNA code, the challenge
ahead lies in the detailed exposure of mechanisms and
modalities of regulation of the proteome, which will give
us tools to understand the intricacy of metabolic networks
[188] and the robustness of complex systems [189].
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